Inflammation, immunity, vaccines for Helicobacter infection

被引:28
作者
Chmiela, Magdalena
Michetti, Pierre
机构
[1] Univ Lodz, Dept Immunol & Infect Dis, PL-90237 Lodz, Poland
[2] Univ Lausanne, CHU Vaudois, Med Ctr, Div Gastroenterol, CH-1011 Lausanne, Switzerland
关键词
Helicobacter pylori; host response; inflammation; vaccines;
D O I
10.1111/j.1478-405X.2006.00422.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The reason why some individuals remain Helicobacterpylori infected for life but without any symptoms while others develop severe diseases is only partially clarified. Presumably, it depends on multifactorial interactions among host immunologic and physiologic factors, bacterial virulence determinants, and environmental influences modulating the host response. Much effort has been made to identify host genetic factors that may explain an individual susceptibility of the host to H. pylori infection. The identification of H. pylori determinants and the elucidation of their role in modifying the host immune responses were further delineated. The ability of H. pylori to overcome the defense mechanisms on mucosal surfaces as well as to modulate the immune response by interfering with host recognition and transduction systems has been shown. Also new bacterial anti-inflammatory defense systems have been described. Findings in experimental animal models and humans with natural H. pylori infection suggested a double role of regulatory T cells in the course of H. pylori infection: protecting the infected host against excessive gastric inflammation and, in contrast, promoting bacterial colonization.
引用
收藏
页码:21 / 26
页数:6
相关论文
共 58 条
[1]
Vaccination prevents Helicobacter pylori-induced alterations of the gastric flora in mice [J].
Aebischer, T ;
Fischer, A ;
Walduck, A ;
Schlötelburg, C ;
Lindig, M ;
Schreiber, S ;
Meyer, TF ;
Bereswill, S ;
Göbel, UB .
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2006, 46 (02) :221-229
[2]
Aebischer T, 2005, HELICOBACTER, V10, P547
[3]
Helicobacter pylori vaccine development:: Facing the challenge [J].
Aebischer, T ;
Schmitt, A ;
Walduck, AK ;
Meyer, TF .
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2005, 295 (05) :343-353
[4]
The nontoxic CTA1-DD adjuvant enhances protective immunity against Helicobacter pylori infection following mucosal immunization [J].
Akhiani, AA ;
Stensson, A ;
Schön, K ;
Lycke, N .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2006, 63 (02) :97-105
[5]
IgA antibodies impair resistance against Helicobacter pylori infection:: Studies on immune evasion in IL-10-deficient mice [J].
Akhiani, AA ;
Stensson, A ;
Schön, K ;
Lycke, NY .
JOURNAL OF IMMUNOLOGY, 2005, 174 (12) :8144-8153
[6]
Induction of CTLA-4-mediated anergy contributes to persistent colonization in the murine model of gastric Helicobacter pylori infection [J].
Anderson, Kathleen M. ;
Czinn, Steven J. ;
Redline, Raymond W. ;
Blanchard, Thomas G. .
JOURNAL OF IMMUNOLOGY, 2006, 176 (09) :5306-5313
[7]
Oral vaccination against Helicobacter pylori infection is not effective in mice with Fas ligand deficiency [J].
Avitzur, Y ;
Galindo-Mata, E ;
Jones, NL .
DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (12) :2300-2306
[8]
B cells pulsed with Helicobacter pylori antigen efficiently activate memory CD8+ T cells from H-pylori-infected individuals [J].
Azem, J ;
Svennerholm, AM ;
Lundin, BS .
CLINICAL IMMUNOLOGY, 2006, 118 (2-3) :284-291
[9]
The secreted peptidyl prolyl cis,trans-isomerase HP0175 of Helicobacter pylori induces apoptosis of gastric epithelial cells in a TLR4- and apoptosis signal-regulating kinase 1-dependent manner [J].
Basak, C ;
Pathak, SK ;
Bhattacharyya, A ;
Pathak, S ;
Basu, J ;
Kundu, M .
JOURNAL OF IMMUNOLOGY, 2005, 174 (09) :5672-5680
[10]
NF-κB- and C/EBPβ-driven interleukin-1β gene expression and PAK1-mediated caspase-1 activation play essential roles in interleukin-1β release from Helicobacter pylori lipopolysaccharide-stimulated macrophages [J].
Basak, C ;
Pathak, SK ;
Bhattacharyya, A ;
Mandal, D ;
Pathak, S ;
Kundu, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (06) :4279-4288